Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists

Details for Australian Patent Application No. 2002248216 (hide)

Owner Bristol-Myers Squibb Pharma Company

Inventors Mitchell, Ian, S.; Chen, Wenting; Robichaud, Albert; Lee, Taekyu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002248216

PCT Pub. Number WO2002/059127

Priority 60/256,765 20.12.00 US

Filing date 19 December 2001

Wipo publication date 6 August 2002

Acceptance publication date 1 March 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248216

1 March 2007 Application Accepted

  Published as AU-B-2002248216

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248217-DUAL CAPILLARY VISCOMETER FOR NEWTONIAN AND NONNEWTONIAN FLUIDS

2002248215-OPTICAL MEMS DEVICE AND PACKAGE HAVING A LIGHTTRANSMISSIVE OPENING OR WINDOW